Skip to main content
Log in

A model for the prospective identification of the prenephrotoxic state during gentamicin therapy

  • Published:
Journal of Pharmacokinetics and Biopharmaceutics Aims and scope Submit manuscript

Abstract

A computer method has been investigated to differentiate the prenephrotoxic patient from the nontoxic patient by routine monitoring of serum gentamicin concentrations duringtherapy, without the need to discontinue medication. The method deliberately assumes an incorreect pharmacokinetic model and uses a nonlinear regression program to analyze data collected during continuous dosing. In principle, it appears that the prenephrotoxic patients may be identified on the basis of a decreasing “apparent” elimination rate constant of gentamicin during continuous therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. W. L. Hewitt. Gentamicin: Toxicity in perspective.Postgrad. Med. J. 50:55–59 (Suppl. 7) (1974).

    PubMed  Google Scholar 

  2. J. J. Schentag and W. J. Jusko. Renal clearance and tissue accumulation of gentamicin in man.Clin. Pharmacol. Ther. 22:364–370 (1977).

    CAS  PubMed  Google Scholar 

  3. M. Gibaldi and H. Weintraub. Some considerations as to the determination and significance of biological half-life.J. Pharm. Sci. 60:624–626 (1971).

    Article  CAS  PubMed  Google Scholar 

  4. J. J. Schentag, W. J. Jusko, J. W. Vance, T. J. Cumbo, E. Abrutyn, M. Delattre, and L. Gerbracht. Gentamicin disposition and tissue accumulation in multiple dosing.J. Pharmacokin. Biopharm. 5:559–577 (1977).

    Article  CAS  Google Scholar 

  5. R. E. Cutler, A. M. Gyselynck, W. P. Fleet, and A. W. Forrey. Correlation of serum creatinine concentration and gentamicin half-life.J. Am. Med. Assoc. 219:1037–1041 (1972).

    Article  CAS  Google Scholar 

  6. R. A. Chan, E. J. Benner, and P. D. Hoeprich. Gentamicin therapy in renal failure: A nomogram for dosage.Ann. Intern. Med. 76:773–778 (1972).

    Article  CAS  PubMed  Google Scholar 

  7. M. C. McHenry, T. L. Gavan, R. W. Gifford, Jr., N. A. Geurkink, M. A. Town, and J. G. Wagner. Gentamicin dosages for renal insufficiency: Adjustments based on endogenous creatinine clearance and serum creatinine concentration.Ann. Intern. Med. 74:192–197 (1971).

    Article  CAS  PubMed  Google Scholar 

  8. W. A. Colburn, D. Shen, and M. Gibaldi. Pharmacokinetic analysis of drug concentration data obtained during repetitive drug administration. I.J. Pharmacokin. Biopharm. 4:469–485 (1976).

    Article  CAS  Google Scholar 

  9. W. A. Colburn and M. Gibaldi. Pharmacokinetic analysis of drug concentration data obtained during repetitive drug administration. II.J. Pharm. Sci. 66:530–533 (1977).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This work was supported in part by Grant No. GM-20852 from the National Institutes of Health.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Colburn, W.A., Schentag, J.J., Jusko, W.J. et al. A model for the prospective identification of the prenephrotoxic state during gentamicin therapy. Journal of Pharmacokinetics and Biopharmaceutics 6, 179–186 (1978). https://doi.org/10.1007/BF01312260

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01312260

Key words

Navigation